Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Guillem Angulo
Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
Ilija Brizic
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Berislav Lisnic
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Tina Jenus
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Vanda Juranic Lisnic
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Gian Pietro Pietri
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Pablo Engel
Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Noa Kaynan
The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute, Hadassah Medical School, The Hebrew University, Jerusalem, Israel
Jelena Zeleznjak
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Peter Schu
Zentrum für Biochemie und Molekulare Zellbiologie Institut für Zellbiochemie, Georg-August-Universität Göttingen, Goettingen, Germany
The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute, Hadassah Medical School, The Hebrew University, Jerusalem, Israel
Astrid Krmpotic
Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Ana Angulo
Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Stipan Jonjic
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Cytomegaloviruses (CMVs) are ubiquitous pathogens known to employ numerous immunoevasive strategies that significantly impair the ability of the immune system to eliminate the infected cells. Here, we report that the single mouse CMV (MCMV) protein, m154, downregulates multiple surface molecules involved in the activation and costimulation of the immune cells. We demonstrate that m154 uses its cytoplasmic tail motif, DD, to interfere with the adaptor protein-1 (AP-1) complex, implicated in intracellular protein sorting and packaging. As a consequence of the perturbed AP-1 sorting, m154 promotes lysosomal degradation of several proteins involved in T cell costimulation, thus impairing virus-specific CD8+ T cell response and virus control in vivo. Additionally, we show that HCMV infection similarly interferes with the AP-1 complex. Altogether, we identify the robust mechanism employed by single viral immunomodulatory protein targeting a broad spectrum of cell surface molecules involved in the antiviral immune response.